PPARG and neoplasm: Clinically, higher PPARγ expression has been correlated with improved prognosis in certain tumor contexts, and epigenetic derepression of PPARG has been associated with enhanced therapeutic responsiveness (132), highlighting its potential as a favorable prognostic biomarker and therapeutic target.